---
title: "Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine"
ocid: "ocds-r6ebe6-0000595876"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000595876"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000595876.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000595876.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"THE AUTHORITY\")"
published: "2020-02-03"
---

# Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY")  
Current stage: Award  
OCID: ocds-r6ebe6-0000595876

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000595876)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000595876.json)

## Summary

The procurement process for the "Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine" contract is being conducted by the Common Services Agency, commonly known as NHS National Services Scotland. This procurement falls under the health sector and is based in Edinburgh. The process is at the planning stage, with a deadline for submissions set for 25th October 2019. The authority is employing an open procurement method, which allows any interested supplier to bid for this framework agreement.

This tender presents substantial opportunities for growth, particularly for businesses operating within the pharmaceutical and medical supply sectors. Notably, companies that can supply generic medicines or have expertise in analgesics and anaesthetics will find this tender appealing. Businesses must be able to demonstrate compliance with pharmaceutical regulations, including possessing valid marketing authorisations and quality certifications, making this an ideal opportunity for large-scale pharmaceutical manufacturers or distributors seeking to establish long-term contracts with NHS entities.

## Notice

Supply of Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicines to NHS Scotland.

### Lot Information

Lot 1 Baclofen Intrathecal Injections

The supply of Baclofen Intrathecal Injections to NHS Scotland in a range of presentations. The Authority has awarded this lot as a single supplier framework.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 2 Oxycodone Injections

The Supply of Oxycodone Injections to NHS Scotland in a range of presentations. The Authority has awarded this lot as a single supplier framework.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 3 Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection

The Supply of Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection to NHS Scotland in a range of presentations. The Authority has awarded this lot as a single supplier framework.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 4 Oxycodone Hydrochloride Prolonged Release Tablets

The Supply of Oxycodone Hydrochloride Prolonged Release Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 5 Buprenorphine Patches

The supply of Buprenorphine Patches to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 6 Fentanyl Tablets (Sublingual)

The Supply of Fentanyl Tablets (Sublingual) to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 7 Fentanyl Sf Tablet (Buccal)

Supply of Fentanyl Sf Tablets(Buccal) to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 8 - Fentanyl Transdermal Patch

Supply of Fentanyl Transdermal Patch to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 9 - Hydromorphone

Supply of Hydromorphone Capsules and Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 10 - Lidocaine Chlorhexidine Gel

Supply of Lidocaine Chlorhexidine Gel to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 11 - Morphine Sulfate Modified-Release capsule (12Hr)

Supply of Morphine Sulfate Modified-Release capsule (12hr) to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 13 - Morphine Sulfate Modified-Release Tablet

The Supply of Morphine Sulfate Modified-Release Tablet to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 12 - Morphine Sulfate Modified-Release capsule (24Hr)

The Supply of Morphine Sulfate Modified-Release capsule (24Hr) to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 14 - Oxycodone Hydrochloride Capsules

The Supply of Oxycodone Hydrochloride Capsules to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 15 - Propofol Injection

The Supply of Propofol Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 16 - Tramadol Hydrochloride Modified Release Tablets

The Supply of Tramadol Hydrochloride Modified Release Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 17 - Oxycodone Oral Solution

The Supply of Oxycodone Oral Solution to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 18 - All Other Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicines

Supply of all other Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine in a range of presentations. The Authority has awarded each line within this Lot as a single Framework.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB379670 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 3 Feb 2020 |
| Submission deadline | 25 Oct 2019 |
| Future notice date | Not specified |
| Award date | 20 Dec 2019 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £38,278,416 |
| Lots value | £38,278,415 |
| Awards value | Not specified |
| Contracts value | £28,229,605 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY") |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 39 |
| Supplier names | ACCORD HEALTHCARE; AGUETTANT; ALTAN PHARMA; ASPEN PHARMA IRELAND; B. BRAUN MEDICAL; BOWMED IBISQUS; CHIESI; CLINIMED; CONSILIENT HEALTH; CRESCENT PHARMA; FOCUS PHARMACEUTICALS; FRESENIUS KABI; GLAXOSMITHKLINE; GRUNENTHAL; HAMELN PHARMACEUTICALS; INTRAPHARM LABORATORIES; JANSSEN-CILAG; KENT PHARMACEUTICALS; KYOWA KIRIN; MARTINDALE PHARMA; MEDREICH; MERCURY PHARMA GROUP; MORNINGSIDE PHARMACEUTICALS; NAPP PHARMACEUTICALS; OPTIMUM MEDICAL SOLUTIONS; PFIZER; PIRAMAL CC; QDEM PHARMACEUTICALS; RANBAXY (UK; SANDOZ; SELECTIVE SUPPLIES; SOUTH DEVON HEALTHCARE NHS FOUNDATIONS TRUST T/A TORBAY PMU; SYRI LIMITED T/A THAME LABORATORIES; TEVA; THORNTON & ROSS; TYPHARM; VIDANT PHARMA; WOCKHARDT; ZENTIVA PHARMA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 3 Feb 2020 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB379670
- 23 Sep 2019 at 00:00 - Tender - OJEU - F2 - Contract Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP367048

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP367048
  Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine - Supply of Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicines to NHS Scotland.
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB379670
  Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine - Supply of Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicines to NHS Scotland.

## Notice URLs

- http://
- http://www.nhsscotlandprocurement.scot.nhs.uk/
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000595876
- https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000595876. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000595876.json.